Antiphospholipid Syndrome  >>  rivaroxaban  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rivaroxaban / Generic mfg.
NCT02926170 / 2010-019764-36: Rivaroxaban for Patients With Antiphospholipid Syndrome

Completed
3
190
Europe
Rivaroxaban, XARELTO, acenocumarol, SINTROM
Hospital Universitari Vall d'Hebron Research Institute
Antiphospholipid Syndrome
12/17
12/17
TRAPS, NCT02157272 / 2013-004575-13: Rivaroxaban in Thrombotic Antiphospholipid Syndrome

Terminated
3
121
Europe
Experimental: Rivaroxaban, Xarelto
University of Padova
Antiphospholipid Syndrome
01/18
01/18

Download Options